Abstract
Radiofrequency (RF) ablation is a thermal therapy that results in coagulation necrosis. Initially, RF ablation was mainly used for treating hepatocellular carcinoma. Favorable outcomes in the treatment of hepatocellular carcinoma have encouraged the application of this technique to neoplasms in other organs, including the lungs. RF ablation for lung cancer may be carried out percutaneously by using computed tomographic (CT) guidance; the techniques used in this therapy are simple and quite similar to those used in CT-guided lung biopsy. Mortality rate has been reported to be 0.4%. There have been promising survival data after RF ablation: 68% at 2 years, 74% at 3 years, and 75% at 2 years for patients with clinical stage I non-small-cell lung cancer; and 66% at 2 years and 46%-48% at 3 years for patients with metastatic colorectal cancer. Therefore, RF ablation of lung cancer is currently one of the hot topics in interventional radiology. In this commentary, we describe the outcomes of RF ablation as a novel therapy for pulmonary metastasis from colorectal cancer.
| Original language | English |
|---|---|
| Title of host publication | Colorectal Cancer: Risk, Diagnosis and Treatments |
| Publisher | Nova Science Publishers, Inc. |
| Pages | 203-208 |
| Number of pages | 6 |
| ISBN (Print) | 9781617613012 |
| Publication status | Published - Jan 2011 |
Fingerprint
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Medicine(all)
Cite this
Radiofrequency ablation as a novel therapy for pulmonary metastasis from colorectal cancer. / Hiraki, Takao; Gobara, Hideo; Mimura, Hidefumi; Kanazawa, Susumu.
Colorectal Cancer: Risk, Diagnosis and Treatments. Nova Science Publishers, Inc., 2011. p. 203-208.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Radiofrequency ablation as a novel therapy for pulmonary metastasis from colorectal cancer
AU - Hiraki, Takao
AU - Gobara, Hideo
AU - Mimura, Hidefumi
AU - Kanazawa, Susumu
PY - 2011/1
Y1 - 2011/1
N2 - Radiofrequency (RF) ablation is a thermal therapy that results in coagulation necrosis. Initially, RF ablation was mainly used for treating hepatocellular carcinoma. Favorable outcomes in the treatment of hepatocellular carcinoma have encouraged the application of this technique to neoplasms in other organs, including the lungs. RF ablation for lung cancer may be carried out percutaneously by using computed tomographic (CT) guidance; the techniques used in this therapy are simple and quite similar to those used in CT-guided lung biopsy. Mortality rate has been reported to be 0.4%. There have been promising survival data after RF ablation: 68% at 2 years, 74% at 3 years, and 75% at 2 years for patients with clinical stage I non-small-cell lung cancer; and 66% at 2 years and 46%-48% at 3 years for patients with metastatic colorectal cancer. Therefore, RF ablation of lung cancer is currently one of the hot topics in interventional radiology. In this commentary, we describe the outcomes of RF ablation as a novel therapy for pulmonary metastasis from colorectal cancer.
AB - Radiofrequency (RF) ablation is a thermal therapy that results in coagulation necrosis. Initially, RF ablation was mainly used for treating hepatocellular carcinoma. Favorable outcomes in the treatment of hepatocellular carcinoma have encouraged the application of this technique to neoplasms in other organs, including the lungs. RF ablation for lung cancer may be carried out percutaneously by using computed tomographic (CT) guidance; the techniques used in this therapy are simple and quite similar to those used in CT-guided lung biopsy. Mortality rate has been reported to be 0.4%. There have been promising survival data after RF ablation: 68% at 2 years, 74% at 3 years, and 75% at 2 years for patients with clinical stage I non-small-cell lung cancer; and 66% at 2 years and 46%-48% at 3 years for patients with metastatic colorectal cancer. Therefore, RF ablation of lung cancer is currently one of the hot topics in interventional radiology. In this commentary, we describe the outcomes of RF ablation as a novel therapy for pulmonary metastasis from colorectal cancer.
UR - http://www.scopus.com/inward/record.url?scp=84892026635&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892026635&partnerID=8YFLogxK
M3 - Chapter
AN - SCOPUS:84892026635
SN - 9781617613012
SP - 203
EP - 208
BT - Colorectal Cancer: Risk, Diagnosis and Treatments
PB - Nova Science Publishers, Inc.
ER -